These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 16670306)

  • 1. OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity.
    Soroosh P; Ine S; Sugamura K; Ishii N
    J Immunol; 2006 May; 176(10):5975-87. PubMed ID: 16670306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.
    Takeda I; Ine S; Killeen N; Ndhlovu LC; Murata K; Satomi S; Sugamura K; Ishii N
    J Immunol; 2004 Mar; 172(6):3580-9. PubMed ID: 15004159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases.
    Murata K; Nose M; Ndhlovu LC; Sato T; Sugamura K; Ishii N
    J Immunol; 2002 Oct; 169(8):4628-36. PubMed ID: 12370402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OX40 signals during priming on dendritic cells inhibit CD4 T cell proliferation: IL-4 switches off OX40 signals enabling rapid proliferation of Th2 effectors.
    Kim MY; Bekiaris V; McConnell FM; Gaspal FM; Raykundalia C; Lane PJ
    J Immunol; 2005 Feb; 174(3):1433-7. PubMed ID: 15661901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
    Dawicki W; Bertram EM; Sharpe AH; Watts TH
    J Immunol; 2004 Nov; 173(10):5944-51. PubMed ID: 15528328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
    Mendel I; Shevach EM
    Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response.
    Gri G; Gallo E; Di Carlo E; Musiani P; Colombo MP
    J Immunol; 2003 Jan; 170(1):99-106. PubMed ID: 12496388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional CD4 T cells after intercellular molecular transfer of 0X40 ligand.
    Baba E; Takahashi Y; Lichtenfeld J; Tanaka R; Yoshida A; Sugamura K; Yamamoto N; Tanaka Y
    J Immunol; 2001 Jul; 167(2):875-83. PubMed ID: 11441094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.
    Gramaglia I; Jember A; Pippig SD; Weinberg AD; Killeen N; Croft M
    J Immunol; 2000 Sep; 165(6):3043-50. PubMed ID: 10975814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.
    Kinnear G; Wood KJ; Fallah-Arani F; Jones ND
    J Immunol; 2013 Aug; 191(3):1465-75. PubMed ID: 23817421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of OX40-OX40 ligand interactions in langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice.
    Sato T; Ishii N; Murata K; Kikuchi K; Nakagawa S; Ndhlovu LC; Sugamura K
    Eur J Immunol; 2002 Nov; 32(11):3326-35. PubMed ID: 12555678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
    J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis.
    Ndhlovu LC; Ishii N; Murata K; Sato T; Sugamura K
    J Immunol; 2001 Sep; 167(5):2991-9. PubMed ID: 11509650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of rat OX40 ligand by monoclonal antibody.
    Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
    Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell co-stimulation through OX40 augments and prolongs T cell cytokine synthesis by stabilization of cytokine mRNA.
    Mestas J; Crampton SP; Hori T; Hughes CC
    Int Immunol; 2005 Jun; 17(6):737-47. PubMed ID: 15908450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OX40 ligation on activated T cells enhances the control of Cryptococcus neoformans and reduces pulmonary eosinophilia.
    Humphreys IR; Edwards L; Walzl G; Rae AJ; Dougan G; Hill S; Hussell T
    J Immunol; 2003 Jun; 170(12):6125-32. PubMed ID: 12794142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of airway tolerance by endotoxin/lipopolysaccharide through promoting OX40L and suppressing antigen-specific Foxp3+ T regulatory cells.
    Duan W; So T; Croft M
    J Immunol; 2008 Dec; 181(12):8650-9. PubMed ID: 19050285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD4+CD3- inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression.
    Kim MY; Anderson G; White A; Jenkinson E; Arlt W; Martensson IL; Erlandsson L; Lane PJ
    J Immunol; 2005 Jun; 174(11):6686-91. PubMed ID: 15905508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells.
    Alharshawi K; Marinelarena A; Kumar P; El-Sayed O; Bhattacharya P; Sun Z; Epstein AL; Maker AV; Prabhakar BS
    Sci Rep; 2017 Jul; 7(1):6594. PubMed ID: 28747670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.